In human colon carcinoma Colo205 and HT29 xenografts grown in human endosialin - transgenic mice, endosialin expression was largely confined to NG2 - expressing perivascular cells and not CD31 - positive endothelial cells.	"human	3	8	Organism"	"colon carcinoma Colo205	9	32	Cancer"	"HT29 xenografts	37	52	Cancer"	"human	62	67	Organism"	"endosialin	68	78	Gene_or_gene_product"	"mice	92	96	Organism"	"endosialin	98	108	Gene_or_gene_product"	"NG2	144	147	Gene_or_gene_product"	"perivascular cells	161	179	Cell"	"CD31	188	192	Gene_or_gene_product"	"endothelial cells	204	221	Cell"	"[{""token"": ""human"", ""start_span"": 3, ""end_span"": 8, ""type"": ""Organism""}, {""token"": ""colon carcinoma Colo205"", ""start_span"": 9, ""end_span"": 32, ""type"": ""Cancer""}, {""token"": ""HT29 xenografts"", ""start_span"": 37, ""end_span"": 52, ""type"": ""Cancer""}, {""token"": ""human"", ""start_span"": 62, ""end_span"": 67, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Gene_or_gene_product""}, {""token"": ""mice"", ""start_span"": 92, ""end_span"": 96, ""type"": ""Organism""}, {""token"": ""endosialin"", ""start_span"": 98, ""end_span"": 108, ""type"": ""Gene_or_gene_product""}, {""token"": ""NG2"", ""start_span"": 144, ""end_span"": 147, ""type"": ""Gene_or_gene_product""}, {""token"": ""perivascular cells"", ""start_span"": 161, ""end_span"": 179, ""type"": ""Cell""}, {""token"": ""CD31"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Gene_or_gene_product""}, {""token"": ""endothelial cells"", ""start_span"": 204, ""end_span"": 221, ""type"": ""Cell""}]"
MATERIALS AND METHODS: Human colon carcinoma ( HT29) and murine squamous carcinoma ( SCCVII) clonal cell lines expressing varying levels of VEGF were established and their response to vandetanib was assessed in tissue culture and as solid tumors.	"Human	23	28	Organism"	"colon carcinoma	29	44	Cancer"	"HT29	47	51	Cell"	"murine	57	63	Organism"	"squamous carcinoma	64	82	Cancer"	"SCCVII	85	91	Cell"	"cell lines	100	110	Cell"	"VEGF	140	144	Gene_or_gene_product"	"vandetanib	184	194	Chemical"	"tissue	211	217	Tissue"	"solid tumors	233	245	Cancer"	"[{""token"": ""Human"", ""start_span"": 23, ""end_span"": 28, ""type"": ""Organism""}, {""token"": ""colon carcinoma"", ""start_span"": 29, ""end_span"": 44, ""type"": ""Cancer""}, {""token"": ""HT29"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Cell""}, {""token"": ""murine"", ""start_span"": 57, ""end_span"": 63, ""type"": ""Organism""}, {""token"": ""squamous carcinoma"", ""start_span"": 64, ""end_span"": 82, ""type"": ""Cancer""}, {""token"": ""SCCVII"", ""start_span"": 85, ""end_span"": 91, ""type"": ""Cell""}, {""token"": ""cell lines"", ""start_span"": 100, ""end_span"": 110, ""type"": ""Cell""}, {""token"": ""VEGF"", ""start_span"": 140, ""end_span"": 144, ""type"": ""Gene_or_gene_product""}, {""token"": ""vandetanib"", ""start_span"": 184, ""end_span"": 194, ""type"": ""Chemical""}, {""token"": ""tissue"", ""start_span"": 211, ""end_span"": 217, ""type"": ""Tissue""}, {""token"": ""solid tumors"", ""start_span"": 233, ""end_span"": 245, ""type"": ""Cancer""}]"
CSC - high cultures and tumors expressed increased levels of the proangiogenic factors vascular endothelial growth factor and stromal - derived factor 1, and when signaling by either factor was blocked, all aspects of angiogenesis observed in CSC - high cultures and tumors, including microvessel density, perfusion, EPC mobilization / recruitment, and stimulation of endothelial cell activity, were reduced to levels comparable with those observed in CSC - low cultures / tumors.	"CSC - high cultures	0	19	Cell"	"tumors	24	30	Cancer"	"vascular endothelial growth factor	87	121	Gene_or_gene_product"	"stromal - derived factor 1	126	152	Gene_or_gene_product"	"CSC - high cultures	243	262	Cell"	"tumors	267	273	Cancer"	"microvessel	285	296	Tissue"	"EPC	317	320	Cell"	"endothelial cell	368	384	Cell"	"CSC - low cultures	452	470	Cell"	"tumors	473	479	Cancer"	"[{""token"": ""CSC - high cultures"", ""start_span"": 0, ""end_span"": 19, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 24, ""end_span"": 30, ""type"": ""Cancer""}, {""token"": ""vascular endothelial growth factor"", ""start_span"": 87, ""end_span"": 121, ""type"": ""Gene_or_gene_product""}, {""token"": ""stromal - derived factor 1"", ""start_span"": 126, ""end_span"": 152, ""type"": ""Gene_or_gene_product""}, {""token"": ""CSC - high cultures"", ""start_span"": 243, ""end_span"": 262, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 267, ""end_span"": 273, ""type"": ""Cancer""}, {""token"": ""microvessel"", ""start_span"": 285, ""end_span"": 296, ""type"": ""Tissue""}, {""token"": ""EPC"", ""start_span"": 317, ""end_span"": 320, ""type"": ""Cell""}, {""token"": ""endothelial cell"", ""start_span"": 368, ""end_span"": 384, ""type"": ""Cell""}, {""token"": ""CSC - low cultures"", ""start_span"": 452, ""end_span"": 470, ""type"": ""Cell""}, {""token"": ""tumors"", ""start_span"": 473, ""end_span"": 479, ""type"": ""Cancer""}]"
